Ermann, D. A., Dranitsaris, G., Blau, S., Peevyhouse, A., Neuhalfen, H., Wahlstrom, S. K., Thompson, S. L., Teschemaker, A., Shetty, V., Narkhede, M. (2025). A real-world comparative analysis of cardiovascular (CV) safety and time to next treatment (TTNT) with acalabrutinib versus ibrutinib in treatment-naive patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e23280